Rohto Pharmaceutical Co.,Ltd. (TYO:4527)
Japan · Delayed Price · Currency is JPY 2,432.50
-32.50 (-1.32%)
Jul 10, 2026, 1:25 PM JST
Rohto Pharmaceutical Stock Forecast
Stock Price Forecast
According to 11 analysts polled by S&P Global, Rohto Pharmaceutical stock has a consensus rating of "Buy" and an average price target of ¥2,942. The average 1-year stock price forecast is 20.94% higher than the current stock price, while the lowest is ¥2,300 (-5.45%) and the highest is ¥3,300 (+35.66%).
Price Target: ¥2,942 (+20.94%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Rohto Pharmaceutical stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 4 | 4 | 4 | 4 |
| Buy | 3 | 3 | 3 | 3 | 4 | 4 |
| Hold | 4 | 4 | 4 | 4 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 11 | 11 | 11 | 11 |
Financial Forecast
Revenue This Year
367.89B
from 343.73B
Increased by 7.03%
Revenue Next Year
383.71B
from 367.89B
Increased by 4.30%
EPS This Year
n/a
EPS Next Year
n/a
Financial currency is JPY.
Revenue Forecast
| Revenue | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | 376.8B | ||
| Avg | 367.9B | ||
| Low | 353.5B |
Revenue Growth
| Revenue Growth | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | 9.6% | ||
| Avg | 7.0% | ||
| Low | 2.8% |
EPS Forecast
| EPS | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | - | ||
| Avg | - | ||
| Low | - |
EPS Growth
| EPS Growth | 2028 | 2029 |
|---|---|---|
| High | - | |
| Avg | - | |
| Low | - |